BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11472566)

  • 1. Expression of intercellular adhesion molecules in epithelioid sarcoma and malignant rhabdoid tumor.
    Saito T; Oda Y; Itakura E; Shiratsuchi H; Kinoshita Y; Oshiro Y; Tamiya S; Hachitanda Y; Iwamoto Y; Tsuneyoshi M
    Pathol Int; 2001 Jul; 51(7):532-42. PubMed ID: 11472566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin subunits of inclusion bodies in rhabdoid cells: immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma.
    Shiratsuchi H; Oshiro Y; Saito T; Itakura E; Kinoshita Y; Tamiya S; Oda Y; Komiyama S; Tsuneyoshi M
    Int J Surg Pathol; 2001 Jan; 9(1):37-48. PubMed ID: 11469343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis.
    Kinoshita Y; Shiratsuchi H; Tamiya S; Oshiro Y; Hachitanda Y; Oda Y; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2001; 127(6):351-8. PubMed ID: 11414195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Iwasaki H; Sonobe H; Goto H; Kusakabe H; Takahira T; Kobayashi C; Kawaguchi K; Saito T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2006 Jun; 19(6):820-31. PubMed ID: 16557275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
    Oda Y; Tsuneyoshi M
    Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Adachi T; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Arch Pathol Lab Med; 2002 Sep; 126(9):1071-8. PubMed ID: 12204056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors.
    Hoot AC; Russo P; Judkins AR; Perlman EJ; Biegel JA
    Am J Surg Pathol; 2004 Nov; 28(11):1485-91. PubMed ID: 15489652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APC and beta-catenin in alveolar soft part sarcoma (ASPS)--immunohistochemical and molecular genetic analysis.
    Kuhnen C; Herter P; Monse H; Kahmann S; Muehlberger T; Vogt PM; Steinau HU; Müller KM; Müller O
    Pathol Res Pract; 2000; 196(5):299-304. PubMed ID: 10834386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas.
    Rocha AS; Soares P; Fonseca E; Cameselle-Teijeiro J; Oliveira MC; Sobrinho-Simões M
    Histopathology; 2003 Jun; 42(6):580-7. PubMed ID: 12786894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
    Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E, N-cadherins and beta-catenin expression in medulloblastoma and atypical teratoid/rhabdoid tumor.
    Utsuki S; Oka H; Sato Y; Tsutiya B; Kondo K; Tanizaki Y; Tanaka S; Fujii K
    Neurol Med Chir (Tokyo); 2004 Aug; 44(8):402-6; discussion 407. PubMed ID: 15508347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.
    Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
    Kuhnen C; Herter P; Müller O; Muehlberger T; Krause L; Homann H; Steinau HU; Müller KM
    Mod Pathol; 2000 Sep; 13(9):1005-13. PubMed ID: 11007041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
    Hornick JL; Dal Cin P; Fletcher CD
    Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series.
    Guillou L; Wadden C; Coindre JM; Krausz T; Fletcher CD
    Am J Surg Pathol; 1997 Feb; 21(2):130-46. PubMed ID: 9042279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-catenin expression and mutational analysis in renal cell carcinomas.
    Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
    Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis.
    Li L; Fan XS; Xia QY; Rao Q; Liu B; Yu B; Shi QL; Lu ZF; Zhou XJ
    Hum Pathol; 2014 Nov; 45(11):2247-54. PubMed ID: 25200863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.